3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Colorectal Neoplasms
86
Ovarian Neoplasms
33
Breast Neoplasms
29
Carcinoma, Non-Small-Cell Lung
28
Colonic Neoplasms
23
Rectal Neoplasms
21
Fallopian Tube Neoplasms
17
Neoplasms
16
Neoplasm Metastasis
13
Carcinoma, Hepatocellular
13
Glioblastoma
11
Lung Neoplasms
10
Brain Neoplasms
8
Carcinoma, Renal Cell
7
Uterine Cervical Neoplasms
6
Parkinson Disease 4, Autosomal Dominant Lewy Body
6
Intestinal Neoplasms
5
Gastrointestinal Neoplasms
5
Digestive System Neoplasms
5
Brenner Tumor
5
Recurrence
4
Peritoneal Neoplasms
4
Glioma
4
Carcinoma, Ovarian Epithelial
4
Adenocarcinoma of Lung
4
Rectal Diseases
3
Non-Squamous Non-Small Cell Lung Cancer
3
Liver Neoplasms
3
Intestinal Diseases
3
Gastrointestinal Diseases
3
Interventions
Glutamine
2
glutamic acid diethyl ester
1
Sugars
1
Sodium Selenite
1
Sodium Chloride
1
Saline Solution
1
Paclitaxel
1
Omeprazole
1
N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid
1
Ketamine
1
Glutamic Acid
1
Duloxetine Hydrochloride
1
Drug Therapy
1
Doxorubicin
1
Dexamethasone
1
Cyclophosphamide
1
Carboplatin
1
Bortezomib
1
Bevacizumab
1
Amifostine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Peripheral Nervous System Diseases
×
Bevacizumab
×
Clear all
NCT04201561
2023-06-26
SELENIUM
Seoul National University Hospital
Phase 3
Unknown
68 enrolled